These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Anthranilic acid-based inhibitors of phosphodiesterase: design, synthesis, and bioactive evaluation. Cheng YD; Hwang TL; Wang HH; Pan TL; Wu CC; Chang WY; Liu YT; Chu TC; Hsieh PW Org Biomol Chem; 2011 Oct; 9(20):7113-25. PubMed ID: 21847495 [TBL] [Abstract][Full Text] [Related]
7. Preparation of novel antibacterial agents. Replacement of the central aromatic ring with heterocycles. Li J; Wakefield BD; Ruble JC; Stiff CM; Romero DL; Marotti KR; Sweeney MT; Zurenko GE; Rohrer DC; Thorarensen A Bioorg Med Chem Lett; 2007 Apr; 17(8):2347-50. PubMed ID: 17350254 [TBL] [Abstract][Full Text] [Related]
8. Anthranilate 4H-oxazol-5-ones: novel small molecule antibacterial acyl carrier protein synthase (AcpS) inhibitors. Gilbert AM; Kirisits M; Toy P; Nunn DS; Failli A; Dushin EG; Novikova E; Petersen PJ; Joseph-McCarthy D; McFadyen I; Fritz CC Bioorg Med Chem Lett; 2004 Jan; 14(1):37-41. PubMed ID: 14684293 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antimicrobial activity of some anthranilic acid derivatives. Kar A; Gugnani HC; Madumere UA Pharmazie; 1980 Aug; 35(8):466-8. PubMed ID: 7433494 [TBL] [Abstract][Full Text] [Related]
10. Tetrahydro anthranilic acid as a surrogate for anthranilic acid: application to the discovery of potent niacin receptor agonists. Raghavan S; Tria GS; Shen HC; Ding FX; Taggart AK; Ren N; Wilsie LC; Krsmanovic ML; Holt TG; Wolff MS; Waters MG; Hammond ML; Tata JR; Colletti SL Bioorg Med Chem Lett; 2008 Jun; 18(11):3163-7. PubMed ID: 18477506 [TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of bioisosteres of a carboxylic acid in a novel class of bacterial translation inhibitors. Ruble JC; Wakefield BD; Kamilar GM; Marotti KR; Melchior E; Sweeney MT; Zurenko GE; Romero DL Bioorg Med Chem Lett; 2007 Jul; 17(14):4040-3. PubMed ID: 17561394 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: length optimization and zero carbon linker oximes. Tang D; Gai Y; Polemeropoulos A; Chen Z; Wang Z; Or YS Bioorg Med Chem Lett; 2008 Sep; 18(18):5078-82. PubMed ID: 18762418 [TBL] [Abstract][Full Text] [Related]
13. Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines. Li X; Hilgers M; Cunningham M; Chen Z; Trzoss M; Zhang J; Kohnen L; Lam T; Creighton C; G C K; Nelson K; Kwan B; Stidham M; Brown-Driver V; Shaw KJ; Finn J Bioorg Med Chem Lett; 2011 Sep; 21(18):5171-6. PubMed ID: 21831637 [TBL] [Abstract][Full Text] [Related]
14. Antimicrobial metabolites from a novel halophilic actinomycete Nocardiopsis terrae YIM 90022. Tian S; Yang Y; Liu K; Xiong Z; Xu L; Zhao L Nat Prod Res; 2014; 28(5):344-6. PubMed ID: 24236566 [TBL] [Abstract][Full Text] [Related]
15. Use of structure-based drug design approaches to obtain novel anthranilic acid acyl carrier protein synthase inhibitors. Joseph-McCarthy D; Parris K; Huang A; Failli A; Quagliato D; Dushin EG; Novikova E; Severina E; Tuckman M; Petersen PJ; Dean C; Fritz CC; Meshulam T; DeCenzo M; Dick L; McFadyen IJ; Somers WS; Lovering F; Gilbert AM J Med Chem; 2005 Dec; 48(25):7960-9. PubMed ID: 16335920 [TBL] [Abstract][Full Text] [Related]
16. Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. Barbachyn MR; Cleek GJ; Dolak LA; Garmon SA; Morris J; Seest EP; Thomas RC; Toops DS; Watt W; Wishka DG; Ford CW; Zurenko GE; Hamel JC; Schaadt RD; Stapert D; Yagi BH; Adams WJ; Friis JM; Slatter JG; Sams JP; Oien NL; Zaya MJ; Wienkers LC; Wynalda MA J Med Chem; 2003 Jan; 46(2):284-302. PubMed ID: 12519066 [TBL] [Abstract][Full Text] [Related]
17. Bacterial targets to antimicrobial leads and development candidates. Rogers BL Curr Opin Drug Discov Devel; 2004 Mar; 7(2):211-22. PubMed ID: 15603255 [TBL] [Abstract][Full Text] [Related]
18. [Linkage of anthranilic and metanilic acid salts of diazonium to pyrazolones]. Stefănescu E; Gheorghită N; Pavelescu M; Pĭsaroc-Doru G Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):313-5. PubMed ID: 3911321 [No Abstract] [Full Text] [Related]
19. Design, synthesis, and structure-activity relationship studies of highly potent novel benzoxazinyl-oxazolidinone antibacterial agents. Xin Q; Fan H; Guo B; He H; Gao S; Wang H; Huang Y; Yang Y J Med Chem; 2011 Nov; 54(21):7493-502. PubMed ID: 21955296 [TBL] [Abstract][Full Text] [Related]
20. Resistance mapping and mode of action of a novel class of antibacterial anthranilic acids: evidence for disruption of cell wall biosynthesis. Mott JE; Shaw BA; Smith JF; Bonin PD; Romero DL; Marotti KR; Miller AA J Antimicrob Chemother; 2008 Oct; 62(4):720-9. PubMed ID: 18567575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]